Trials / Completed
CompletedNCT03531697
Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery
A Randomized, Single-blind, Cross-over Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 381 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Generic Loteprednol Etabonate | Drug |
| DRUG | Reference Listed Drug (RLD) | Drug |
Timeline
- Start date
- 2018-04-26
- Primary completion
- 2019-09-07
- Completion
- 2019-10-07
- First posted
- 2018-05-22
- Last updated
- 2019-11-06
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03531697. Inclusion in this directory is not an endorsement.